Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced on 3/7/19 the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) for... read more
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced on 3/7/19 the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) for... read more
Israeli healthcare-focused VC fund aMoon Partners has finalized $660 million in investor commitments for it second fund (aMoon II), making it the largest single fund in Israel. The fund, run by... read more
Xenetic Biosciences, Inc. (NASDAQ: XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology... read more
On 3/4/19 Silk Road Medical Filed for an upcoming $86 Million IPO. The Sunnyvale, CA based company has introduced the TCAR procedure intended to reduce the risk embolic debris entering the brain... read more
Abpro, a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases, and NJCTTQ, a global... read more